Skip to main content
. 2024 Jun 27;4(6):1597–1608. doi: 10.1158/2767-9764.CRC-24-0026

TABLE 2.

ESR1 locus variants and TP53 mutation associations

SNV Ref Allele rs9397436 T rs9383938 G rs9479090 A
TP53 Mutation Any LOF GOF Any GOF Any
Discovery Cases/Controls 853/1,797 516/1,797 236/1,797 1,073/2,242 292/2,242 1,106/2,303
Discovery OR 1.53 1.48 1.79 1.46 1.71 1.44
Discovery P 1.39E-05 6.9E-04 1.1E-04 6.8E-05 3.5E-05 5.4E-05
Discovery MAF 8.4% 10.0% 11.0%
EUR Valid Cases/Controls 217/356 132/356 67/356 130/227 34/227 215/357
EUR Valid OR 1.14 1.04 1.17 1.04 0.96 1.06
EUR Valid P 0.55 0.89 0.66 0.87 0.92 0.8
EUR MAF 9.4% 9.4% 10.7%
MyBrCa Cases/Controls 369/490 241/490 114/490 369/490 114/490 369/490
MyBrCa OR 1.43 1.35 1.51 1.81 2.07 1.76
MyBrCa P 0.001 0.02 0.01 9.8E-08* 8.4E-06* 2.8E-07*
MyBrCa MAF 37.3% 37.7% 38.1%
Combined Cases/Controls 1,439/2,643 889/2,643 417/2,643 1,572/2,959 440/2,959 1,690/3,150
Combined OR (95% CI) 1.35 (1.17–1.54) 1.24 (1.06–1.46) 1.53 (1.25–1.88) 1.47 (1.31–1.66) 1.59 (1.32–1.90) 1.42 (1.27–1.59)
Combined P 1.8E-05a 0.007 3.5E-05a 2.0E-10a 6.07E-07a 4.6E-10a

Abbreviations: 95% CI, 95% confidence interval; EUR Valid, European ancestry Validation Study; GOF, gain of function; LOF, loss of function; MAF, minor allele frequency; OR, odds ratio; P, P values; Ref allele, reference allele.

a Significant after multiple comparisons corrections.